Defining anticipatory nausea and vomiting: Differences among cancer chemotherapy patients who report pretreatment nausea

1988 ◽  
Vol 11 (1) ◽  
pp. 59-69 ◽  
Author(s):  
Michael A. Andrykowski
2007 ◽  
Vol 5 (1) ◽  
pp. 44-50 ◽  
Author(s):  
Colmar Figueroa-Moseley ◽  
Pascal Jean-Pierre ◽  
Joseph A. Roscoe ◽  
Julie L. Ryan ◽  
Sadhna Kohli ◽  
...  

Anticipatory nausea and vomiting (ANV) is associated with a significant reduction in the quality of life for many chemotherapy patients. The use of 5-hydroxytryptamine type 3 receptor antagonists provides some relief for chemotherapy-induced nausea and vomiting, but does not seem to control ANV. Nonpharmacologic approaches, which include behavioral interventions, may provide the greatest promise in relieving symptoms. Little evidence supports the use of complementary and alternative methods, such as acupuncture and acupressure, in relieving ANV. Behavioral interventions, especially progressive muscle relaxation training and systematic desensitization, should be considered important methods for preventing and treating ANV.


Oncology ◽  
2000 ◽  
Vol 59 (2) ◽  
pp. 100-104 ◽  
Author(s):  
Giovanni Marchioro ◽  
Giuseppe Azzarello ◽  
Franco Viviani ◽  
Fiorenza Barbato ◽  
Michela Pavanetto ◽  
...  

1984 ◽  
Vol 28 (1) ◽  
pp. 73-77 ◽  
Author(s):  
William W. Weddington ◽  
Nancy J. Miller ◽  
Donald L. Sweet

1992 ◽  
Vol 15 (3) ◽  
pp. 262-267 ◽  
Author(s):  
Sandra B. Y. Chin ◽  
Omer Kucuk ◽  
Rolf Peterson ◽  
Ediz Z. Ezdinli

Oncology ◽  
1989 ◽  
Vol 46 (1) ◽  
pp. 26-30 ◽  
Author(s):  
Emilio Alba ◽  
Romá Bastus ◽  
Luis de Andres ◽  
Claudio Sola ◽  
Alfredo Paredes ◽  
...  

1986 ◽  
Vol 30 (6) ◽  
pp. 643-654 ◽  
Author(s):  
Randye E. Cohen ◽  
Edward B. Blanchard ◽  
John C. Ruckdeschel ◽  
Robert C. Smolen

Sign in / Sign up

Export Citation Format

Share Document